| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.007 |